PAH demands urgency... Impact now, don’t wait to turn to treprostinil PAH demands urgency... Impact now, don’t wait to turn to treprostinil

PAH=pulmonary arterial hypertension; WHO=World Health Organization.

Understanding PAH

PAH is a progressive disease. PAH may be progressing even if patients do not appear symptomatic.1

LEARN ABOUT DISEASE PROGRESSION

PAH pathways

Expert guidelines outline the prostacyclin pathway as one of 3 treatment pathways that may help treat patients with PAH.2

LEARN ABOUT THE
PROSTACYCLIN PATHWAY

Treprostinil—one molecule over the course of disease

For PAH, United Therapeutics provides a range of treprostinil formulations—oral, inhaled, and SC/IV.3-5 Learn more about what they could do for your patients.

TREPROSTINIL
IV=intravenous; SC=subcutaneous.

Supporting PAH
patients together

United Therapeutics is committed to educating and providing support for PAH patients and their families.

LEARN MORE